Array Comparative Genomic Hybridization

Array comparative genomic hybridization, often abbreviated as array CGH, is a powerful laboratory technique used to detect and analyze changes in DNA copy number across the genome. This method has revolutionized the field of genetics and molecular diagnostics by providing a high-resolution way to identify genetic abnormalities that may be associated with various medical conditions. Unlike traditional karyotyping, which relies on visualizing chromosomes under a microscope, array CGH can detect much smaller deletions or duplications, offering a more detailed view of the genome. Patients with unexplained developmental delays, congenital anomalies, or infertility often benefit from this type of genetic testing, as it can reveal underlying chromosomal imbalances that may not be apparent through standard testing methods.

Understanding the Basics of Array CGH

Array comparative genomic hybridization is designed to compare the DNA of a patient with a reference DNA sample. By labeling the patient’s DNA and the reference DNA with different fluorescent dyes, the two samples are applied to a microarray containing thousands of DNA probes. These probes correspond to specific regions of the genome. When the patient’s DNA binds more strongly to a probe than the reference DNA, it indicates a duplication in that region. Conversely, weaker binding suggests a deletion. This approach allows scientists and clinicians to detect copy number variations (CNVs) with remarkable precision.

How Array CGH Differs from Traditional Techniques

Traditional cytogenetic techniques, such as karyotyping and fluorescence in situ hybridization (FISH), have limitations in resolution. Karyotyping can detect large chromosomal changes but often misses small deletions or duplications. FISH improves resolution but typically targets only specific regions of interest. In contrast, array CGH provides a genome-wide analysis, scanning thousands of regions simultaneously, which makes it more effective in identifying subtle genetic abnormalities that might otherwise remain undetected.

Applications of Array CGH in Medicine

Array CGH has become an essential tool in modern genetics and medical diagnostics. Its applications span a variety of fields, including prenatal testing, cancer research, and rare disease diagnosis. Some of the most common uses include

• Identifying genetic causes of developmental delays and intellectual disabilities in children.
• Detecting chromosomal abnormalities in prenatal samples, such as amniotic fluid or chorionic villus samples.
• Diagnosing genetic syndromes that involve microdeletions or microduplications.
• Investigating chromosomal imbalances in cancer cells to understand tumor development and progression.
• Screening for genetic changes that may contribute to infertility or recurrent pregnancy loss.

Array CGH in Prenatal Diagnosis

In prenatal medicine, array CGH is increasingly used when standard karyotyping results are normal, but the fetus presents with structural anomalies on ultrasound. The high resolution of array CGH allows clinicians to detect subtle chromosomal changes that could explain developmental issues. This enables better counseling for parents regarding potential outcomes and treatment options. While the method provides detailed information, it also requires careful interpretation to distinguish between benign variations and clinically significant abnormalities.

Technical Aspects of Array CGH

The process of array CGH involves several key steps. First, DNA is extracted from the patient and reference samples. Next, the DNA is labeled with fluorescent dyes, commonly red for the patient and green for the reference. The labeled DNA is then hybridized onto a microarray chip that contains thousands of DNA probes. After hybridization, the microarray is scanned using a specialized instrument that measures the intensity of fluorescence at each probe. The resulting data is analyzed using software to detect regions of duplication or deletion, which are visualized as peaks or valleys on a genome-wide plot.

Types of Arrays Used

Array CGH platforms can vary based on the type of probes used and the density of the array. Some common types include

• Bacterial artificial chromosome (BAC) arrays, which use large DNA fragments and are suitable for detecting larger chromosomal changes.
• Oligonucleotide arrays, which use shorter DNA sequences and offer higher resolution for detecting small copy number variations.
• Single nucleotide polymorphism (SNP) arrays, which combine CNV detection with genotyping capabilities, providing additional insights into genetic variations.

Advantages and Limitations

Array CGH provides several advantages over traditional cytogenetic methods. Its high resolution allows for the detection of submicroscopic deletions and duplications, and it can screen the entire genome simultaneously. This makes it particularly useful for identifying rare genetic conditions that might not be diagnosed through conventional techniques. Additionally, the process is relatively fast, and the results can be more consistent compared to manual chromosome analysis.

Limitations to Consider

Despite its many benefits, array CGH also has limitations. It cannot detect balanced translocations or inversions, where the total amount of DNA remains unchanged. Similarly, it does not provide information about the structural organization of chromosomes. Interpretation of results can also be complex, especially when variants of uncertain significance are detected. Genetic counseling is often necessary to help patients understand the implications of the findings and to guide clinical decision-making.

Future Perspectives of Array CGH

The field of array CGH continues to evolve, with advances in technology increasing both the resolution and accuracy of the technique. Newer arrays are capable of detecting smaller copy number variations and integrating additional data types, such as methylation patterns and gene expression profiles. As genomic research progresses, array CGH is expected to play an even more significant role in personalized medicine, allowing tailored treatment plans based on an individual’s unique genetic profile. Combining array CGH with next-generation sequencing and other genomic tools may provide comprehensive insights into genetic disorders and cancer biology.

Array comparative genomic hybridization has transformed genetic diagnostics by providing a detailed and comprehensive method for detecting DNA copy number variations. Its applications in prenatal testing, developmental disorders, cancer research, and rare disease diagnosis make it a critical tool in modern medicine. While there are limitations, the high-resolution data it provides helps clinicians and researchers better understand the genetic basis of disease. As technology advances, array CGH will likely continue to enhance our ability to diagnose, manage, and potentially prevent genetic conditions, paving the way for more precise and individualized healthcare solutions.